Answers from the Lab

Michelle Kluge, M.S., CGC, discusses Mayo Clinic Laboratories' in-depth molecular genetic testing for congenital adrenal hypoplasia. The most common form of this inherited autosomal recessive condition is caused by pathogenic variants in the CYP21A2 gene. MCL's approach avoids the limitations of standard next generation sequencing assays, allowing for a detection rate of greater than 99% for patients with a clinical diagnosis of 21-hydroxylase deficient CAH.

Show Notes

(00:32):
Can you tell us a little about yourself and your background? What is the role of a genetic counselor in the Genomics Laboratory?

(01:59):
The Genomics Laboratory performs a lot of different genetic tests. What is your area of focus?

(03:00):
Give a brief overview of congenital adrenal hyperplasia.

(05:44):
Which patients should have this testing, and when should it be performed?

(06:35):
Can you tell us a bit about what sets MCL’s CYP21A2 offering apart from other labs?

(08:18):
What are some examples of external results that you have helped resolve?

(10:51):
Do you get calls asking for help interpreting CYP21A2 test results?

What is Answers from the Lab?

A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.